Mild Versus Potent Corticosteroids as Treatment for Phimosis in Children (TopSteP)

Chelsea and Westminster NHS Foundation Trust

Status and phase: Withdrawn; Phase 4

Conditions: Phimosis

Treatments: Drug: hydrocortisone; Drug: Betamethasone

Study type: Interventional

Funder types: Other

Identifiers

NCT00933023

TopSteP

Details and patient eligibility

About

Topical steroids are used as treatment for non-retractile foreskin in children for decades, but, there are disagreement among physicians about the optimum potency of the agent used. This study is designed to determine any difference in the beneficial effects of mild versus potent topical corticosteroids in treatment of non-retractile foreskin in children.

Sex: Male

Ages: 2 to 16 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Children 2-16 with non-retractile foreskin

Exclusion criteria

• Balanitis xerotica obliterans, balanitis, <2yrs

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

0 participants in 2 patient groups

Mild steroid

Experimental group

Description:

1%hydrocortisone for 8 weeks

Treatment:

Drug: hydrocortisone

Potent Steroid

Experimental group

Treatment:

Drug: Betamethasone